Besides the genotype influencing the expression level, the A55V polymorphism causing the UCP2 dysfunction also increased the risk of cardiovascular events in patients with CAD (Gioli-Pereira et al., 2013). The gene discussed is UCP2; the disease is coronary artery disorder.